The study determined the relationship between miR‐676‐3p, CASC11, and NOL4L based on bioinformatics tools and found that high expression of NOL4L reversed the effects of CASC11 on neonatal neuroblastoma, including inhibition of proliferation or proliferation. Here, CASC11 is linked to neuroblastoma.